CR11221A - Estirpes celulares aviares inmortalizadas - Google Patents
Estirpes celulares aviares inmortalizadasInfo
- Publication number
- CR11221A CR11221A CR11221A CR11221A CR11221A CR 11221 A CR11221 A CR 11221A CR 11221 A CR11221 A CR 11221A CR 11221 A CR11221 A CR 11221A CR 11221 A CR11221 A CR 11221A
- Authority
- CR
- Costa Rica
- Prior art keywords
- immortalized
- stones
- cells
- aircraft cellular
- aircraft
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24151—Methods of production or purification of viral material
- C12N2710/24152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/80—Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Mycology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente invencion se refiere a celulas aviares inmortalizadas, y al uso de estas celulas para la produccion de virus. Las celulas segun la invencion son particularmente utiles para la produccion de vectores viricos recombinantes que se pueden usar para la preparacion de composiciones terapeuticas y/o profilacticas para el tratamiento de animales, y mas particularmente seres humanos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07360030 | 2007-07-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR11221A true CR11221A (es) | 2010-03-22 |
Family
ID=39767102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR11221A CR11221A (es) | 2007-07-03 | 2010-01-15 | Estirpes celulares aviares inmortalizadas |
Country Status (15)
Country | Link |
---|---|
US (2) | US8361788B2 (es) |
EP (1) | EP2176398B1 (es) |
JP (1) | JP5421250B2 (es) |
KR (1) | KR101528379B1 (es) |
CN (1) | CN101688182A (es) |
AU (1) | AU2008270317B2 (es) |
BR (1) | BRPI0811787B1 (es) |
CA (1) | CA2691868C (es) |
CR (1) | CR11221A (es) |
ES (1) | ES2618490T3 (es) |
IL (1) | IL203029A (es) |
RU (1) | RU2475536C2 (es) |
TW (1) | TWI614342B (es) |
WO (1) | WO2009004016A1 (es) |
ZA (1) | ZA201000251B (es) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8357531B2 (en) | 2007-07-03 | 2013-01-22 | Transgene S.A. | Immortalized avian cell lines |
CA2760465A1 (en) * | 2009-05-12 | 2010-11-18 | Transgene Sa | Method for orthopoxvirus production and purification |
WO2011095596A1 (en) | 2010-02-04 | 2011-08-11 | Vivalis | Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells |
FR2956409A1 (fr) | 2010-02-15 | 2011-08-19 | Univ Claude Bernard Lyon | Procedes pour optimiser la production virale par l'inactivation ou l'inhibition du gene hipk2 et cellules modifiees pour la production virale |
FR2967072B1 (fr) | 2010-11-05 | 2013-03-29 | Univ Dundee | Procede pour ameliorer la production de virus et semences vaccinales influenza |
WO2012095514A1 (en) | 2011-01-14 | 2012-07-19 | Vivalis | Recombinant protein production system |
US20140287402A1 (en) | 2011-06-27 | 2014-09-25 | Valneva | Method for screening cells |
TWI575070B (zh) | 2011-07-12 | 2017-03-21 | 傳斯堅公司 | Hbv聚合酶突變體 |
TW201321016A (zh) | 2011-09-29 | 2013-06-01 | Transgene Sa | 免疫療法組成物及用於治療c型肝炎病毒感染之療程(二) |
TW201318637A (zh) | 2011-09-29 | 2013-05-16 | Transgene Sa | 免疫療法組成物及用於治療c型肝炎病毒感染之療程(一) |
SG11201500171YA (en) | 2012-07-10 | 2015-02-27 | Transgene Sa | Mycobacterial antigen vaccine |
WO2014009433A1 (en) | 2012-07-10 | 2014-01-16 | Transgene Sa | Mycobacterium resuscitation promoting factor for use as adjuvant |
CN104726409B (zh) * | 2013-12-19 | 2017-12-29 | 普莱柯生物工程股份有限公司 | 一种永生化的鸭胚肝细胞系的制备方法和应用 |
US10765731B2 (en) | 2014-01-09 | 2020-09-08 | Transgene Sa | Fusion of heterooligomeric mycobacterial antigens |
DK3226894T3 (da) | 2014-12-01 | 2019-10-21 | Transgene Sa | Stabile flydende vacciniavirus-formuleringer |
US10428316B2 (en) | 2014-12-04 | 2019-10-01 | Intervet Inc. | Immortalised chicken embryo fibroblasts |
EP3452081A1 (en) | 2016-05-04 | 2019-03-13 | Transgene SA | Combination therapy with cpg tlr9 ligand |
WO2018069316A2 (en) | 2016-10-10 | 2018-04-19 | Transgene Sa | Immunotherapeutic product and mdsc modulator combination therapy |
CN110603058A (zh) | 2017-05-15 | 2019-12-20 | 扬森疫苗与预防公司 | 含有病毒的稳定组合物 |
CA3062549A1 (en) | 2017-05-15 | 2018-11-22 | Janssen Vaccines & Prevention B.V. | Stable virus-containing composition |
EP3641803A2 (en) | 2017-06-21 | 2020-04-29 | Transgene | Personalized vaccine |
JP7437385B2 (ja) | 2018-09-06 | 2024-02-22 | バヴァリアン・ノルディック・アクティーゼルスカブ | 保管が改善されたポックスウイルス組成物 |
JP2022510147A (ja) | 2018-11-23 | 2022-01-26 | ヴァルネヴァ エスイー | 鳥類幹細胞を含む食品 |
FR3089789B1 (fr) | 2018-12-14 | 2022-05-27 | Univ Claude Bernard Lyon | Production de vaccins viraux sur une lignee cellulaire aviaire |
EP3842065A1 (en) | 2019-12-23 | 2021-06-30 | Transgene | Process for designing a recombinant poxvirus for a therapeutic vaccine |
KR20220153587A (ko) | 2020-03-12 | 2022-11-18 | 버베리안 노딕 에이/에스 | 폭스바이러스 안정성을 개선하는 조성물 |
WO2022013221A1 (en) | 2020-07-13 | 2022-01-20 | Transgene | Treatment of immune depression |
WO2023213764A1 (en) | 2022-05-02 | 2023-11-09 | Transgene | Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf |
WO2023213763A1 (en) | 2022-05-02 | 2023-11-09 | Transgene | Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2749021B1 (fr) * | 1996-05-23 | 2001-10-26 | Agronomique Inst Nat Rech | Lignees de cellules aviaires immortalisees |
US5672485A (en) * | 1996-08-13 | 1997-09-30 | Regents Of The University Of Minnesota | Immortalized cell lines for virus growth |
FR2777570A1 (fr) * | 1998-04-17 | 1999-10-22 | Transgene Sa | Mutant ayant une activite phosphoribosyl transferase |
EP1103610A1 (en) * | 1999-11-26 | 2001-05-30 | Introgene B.V. | Production of vaccines from immortalised mammalian cell lines |
FR2836924B1 (fr) * | 2002-03-08 | 2005-01-14 | Vivalis | Lignees de cellules aviaires utiles pour la production de substances d'interet |
PL1649023T3 (pl) | 2003-07-21 | 2009-01-30 | Transgene Sa | Polipeptyd o podwyższonej aktywności deaminazy cytozyny |
AU2004257939B2 (en) | 2003-07-22 | 2008-06-05 | Valneva | Production of poxviruses with adherent or non adherent avian cell lines |
EP1528101A1 (en) * | 2003-11-03 | 2005-05-04 | ProBioGen AG | Immortalized avian cell lines for virus production |
-
2008
- 2008-07-02 JP JP2010513972A patent/JP5421250B2/ja active Active
- 2008-07-02 TW TW097124986A patent/TWI614342B/zh not_active IP Right Cessation
- 2008-07-02 RU RU2010102668/10A patent/RU2475536C2/ru active
- 2008-07-02 WO PCT/EP2008/058472 patent/WO2009004016A1/en active Application Filing
- 2008-07-02 CN CN200880023138A patent/CN101688182A/zh active Pending
- 2008-07-02 US US12/667,240 patent/US8361788B2/en active Active
- 2008-07-02 CA CA2691868A patent/CA2691868C/en active Active
- 2008-07-02 AU AU2008270317A patent/AU2008270317B2/en not_active Ceased
- 2008-07-02 KR KR1020107001319A patent/KR101528379B1/ko active IP Right Grant
- 2008-07-02 ES ES08785896.5T patent/ES2618490T3/es active Active
- 2008-07-02 EP EP08785896.5A patent/EP2176398B1/en active Active
- 2008-07-02 BR BRPI0811787A patent/BRPI0811787B1/pt not_active IP Right Cessation
-
2009
- 2009-12-29 IL IL203029A patent/IL203029A/en active IP Right Grant
-
2010
- 2010-01-13 ZA ZA201000251A patent/ZA201000251B/xx unknown
- 2010-01-15 CR CR11221A patent/CR11221A/es not_active Application Discontinuation
-
2012
- 2012-12-21 US US13/723,946 patent/US8809056B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
AU2008270317A1 (en) | 2009-01-08 |
US8361788B2 (en) | 2013-01-29 |
KR20100035650A (ko) | 2010-04-05 |
EP2176398A1 (en) | 2010-04-21 |
KR101528379B1 (ko) | 2015-06-16 |
JP5421250B2 (ja) | 2014-02-19 |
CA2691868A1 (en) | 2009-01-08 |
CN101688182A (zh) | 2010-03-31 |
RU2010102668A (ru) | 2011-08-10 |
US8809056B2 (en) | 2014-08-19 |
US20100197010A1 (en) | 2010-08-05 |
BRPI0811787A2 (pt) | 2014-12-30 |
ES2618490T3 (es) | 2017-06-21 |
US20130244246A1 (en) | 2013-09-19 |
ZA201000251B (en) | 2010-09-29 |
AU2008270317B2 (en) | 2013-12-05 |
TWI614342B (zh) | 2018-02-11 |
WO2009004016A1 (en) | 2009-01-08 |
TW200911994A (en) | 2009-03-16 |
BRPI0811787B1 (pt) | 2018-10-09 |
RU2475536C2 (ru) | 2013-02-20 |
IL203029A (en) | 2013-07-31 |
CA2691868C (en) | 2016-12-20 |
JP2010531654A (ja) | 2010-09-30 |
EP2176398B1 (en) | 2016-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR11221A (es) | Estirpes celulares aviares inmortalizadas | |
UY36966A (es) | Derivados de heterociclos bicíclicos fusionados como plaguicidas | |
CL2021000088A1 (es) | Anticuerpos anti-cd27 (divisional de solicitud 779-2019). | |
UY31484A1 (es) | Piperidinas heteroaril-sustituidas | |
HN2008000087A (es) | Inhibidores de la proteasa ns3 del vhc | |
CR9131A (es) | Oligonucleotidos inmunoestimuladores de clase c semiblandos | |
UY33625A (es) | Uso de ingredientes activos para controlar nematodos en cultivos resistentes a nematodos | |
NI201000044A (es) | Bromhidrato de bupropión y aplicaciones terapéuticas | |
PA8660301A1 (es) | Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricacion y utilizacion | |
PA8772101A1 (es) | Imidazol-triazolopirimidinas sustituidas | |
CY1117778T1 (el) | Βελτιωμενη ανασυνδυασμενη ανθρωπινη ωοθυλακιοτροπο ορμονη | |
ECSP109923A (es) | Bromhidrato de bupropion y aplicaciones terapéuticas | |
CO6670575A2 (es) | Aminopirazoloqinazolinas sustituidas, útiles en el tratamiento de enfermedades proliferativas y composiciones farmaceúticas que las continen | |
CL2020001797A1 (es) | Compuestos, composiciones y métodos para tratar enfermedades que involucren tejidos con enfermedades ácidas o hipóxicas. | |
UY32457A (es) | Vacuna del virus del dengue inactivado | |
GT201000069A (es) | Derivados de quinazolinadiona, su preparacion y sus aplicaciones terapeuticas | |
CR11562A (es) | Bis-piridilpiridonas como antagonistas del receptor 1 de la hormona concentradora de melanina | |
UY31133A1 (es) | "oxazolidinonas sustituidas y su uso" | |
HN2003000080A (es) | Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos y procedimientos para su uso | |
CO2020003475A2 (es) | Sulfonas y sulfóxidos bicíclicos y métodos de uso de los mismos | |
ECSP20082988A (es) | Agonistas de tlr7 | |
PA8624401A1 (es) | Procesos para la preparacion de haluros de aril- y heteroaril-alquilsulfonilo | |
AR053775A1 (es) | Nonadepsipeptidos acilados ii | |
PA8661701A1 (es) | Tiazolidinonas, su preparacion y su uso como medicamento | |
CL2021000129A1 (es) | Apirasas solubilizadas, métodos y usos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |